 Braxia Scientific Corp. CSE:BRAX, OTC:BRAXF told investors it has reached agreements to settle class actions in the US and Canada pending court approval. The US class action against the company and certain of its former officers was filed in the United States District Court for the Central District of California in April, 2021, while the Canadian Class Action was filed in the British Columbia Supreme Court in May 2021 against the company, its CEO, certain of its former officers, a shareholder, and underwriters. 